Ingestion of Lacticaseibacillus rhamnosus Fmb14 prevents depression-like behavior and brain neural activity via the microbiota–gut–brain axis in colitis mice
- 27 January 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 14 (4), 1909-1928
- https://doi.org/10.1039/d2fo04014j
Abstract
Large preclinical evidence suggested that colitis was one of the risk factors for depression and probiotics were effective therapeutic agents to prevent the disease. The effect of Lacticaseibacillus rhamnosus Fmb14 on colitis-related depression-like behavior and its possible mechanisms were investigated. One week of DSS exposure led to the following changes in male C57BL/6N mice: a reduction in the movement distance from 2218 to 1299 cm, time in central areas from 23.6 s to 11.5 s, and time in the bright box from 217 s to 103 s, which were restored to 1816 cm, 18.4 s, and 181 s, respectively, with preadministration of Fmb14 for 8 weeks. All improvements provided by Fmb14 indicated a remarkable protective effect on depression-like behavior. Fmb14 first worked to repair intestinal barrier damage and the inflammatory response in the colon through ZO1 and Ocln enhancement and IL-1β, NF-κB and IL-6 reduction, respectively. Second, dysbiosis of the gut microbiota was modulated by Fmb14, including reduction of Akkermansia (18.9% to 5.4%), Mucispirillum (0.6% to 0.1%) and Bifidobacterium (0.32% to 0.03%). Fmb14 supplementation ameliorates the brain inflammatory response via IL-18 and NF-κB reduction and improves the blood–brain barrier via increased levels of ZO1 and Ocln. Moreover, brain activity was facilitated by an increase in BDNF and dopamine and the downregulation of GABA in the Fmb14 group. As a consequence of the modulatory effect on the dysfunction of neurotransmitters and neuroinflammation, Fmb14 prevents neurodegeneration by inhibiting neuronal apoptosis and Nissl edema. In addition, the correlation analysis further demonstrated the preventative effect of Fmb14 on depression-like behavior through the microbiota–gut–brain axis. Together, these findings demonstrated the important role of Fmb14 in biological signal transduction over the microbiota–gut–brain axis to improve mood disorders.Keywords
Funding Information
- National Natural Science Foundation of China (32072182)
This publication has 84 references indexed in Scilit:
- Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental DisordersCell, 2013
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesityProceedings of the National Academy of Sciences of the United States of America, 2013
- Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerveProceedings of the National Academy of Sciences of the United States of America, 2011
- Bacterial infection causes stress-induced memory dysfunction in miceGut, 2010
- Revisiting the parietal cellAmerican Journal of Physiology-Cell Physiology, 2010
- A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease?American Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Role of the Brain-Gut Axis in the Pathophysiology of Crohn’s DiseaseDigestive Diseases, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- The Blood-Brain Barrier/Neurovascular Unit in Health and DiseasePharmacological Reviews, 2005
- Analysis of GABAA Receptor Function and Dissection of the Pharmacology of Benzodiazepines and General Anesthetics Through Mouse GeneticsAnnual Review of Pharmacology and Toxicology, 2004